Regulations.gov document
Draft Guidances Relating to the Development of Human Gene Therapy Products; Availability…
Notice · FDA-1999-D-0081 · posted Sep 6, 2018
Key facts
| Document ID | FDA-1999-D-0081-0039 |
|---|---|
| Title | Draft Guidances Relating to the Development of Human Gene Therapy Products; Availability; Extension of Comment Period |
| Document type | Notice |
| Subtype | Extension of Comment Period |
| Agency | FDA |
| Docket | FDA-1999-D-0081 |
| Posted | Sep 6, 2018 |
| Federal Register citation | 83 FR 45249 |
| FR document number | 2018-19303 |
| Comment period opens | Sep 6, 2018 |
| Comments due | Dec 11, 2018 |
| Effective date | Sep 6, 2018 |
At a glance
- 1–9 Pages
- No Open for comment
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: